Pricing Log in Create free account

Aligos Therapeutics, Inc. (ALGS) vs Annovis Bio, Inc. (ANVS)

Aligos Therapeutics, Inc. and Annovis Bio, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and Annovis Bio, Inc. are of similar size ($28.6M and $28.2M). Annovis Bio, Inc. has the higher net margin (0.00% vs −197.0%) and the higher return on invested capital (0.00% vs −400.9%). Across the 11 metrics below, Annovis Bio, Inc. leads on 7 and Aligos Therapeutics, Inc. on 4.

Valuation

Metric ALGS ANVS Biotechnology median
P/E n/m n/m 10.60
P/S 1.27 n/m 9.40
P/B 3.78 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.37 n/m 9.02
Earnings yield (155.26%) (218.29%) (32.88%)
Free cash flow yield (160.62%) (140.87%) (23.13%)

Profitability

Metric ALGS ANVS Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (215.55%) 0.00% 0.00%
Net margin (197.01%) 0.00% 0.00%
Free cash flow margin (203.21%) 0.00% 0.00%
Return on equity (159.46%) (703.68%) (51.96%)
Return on assets (84.46%) (227.74%) (46.06%)
Return on invested capital (400.91%) 0.00% 0.00%

Growth

Metric ALGS ANVS Biotechnology median
Revenue growth (TTM) 1,171.58% — 6.76%
EPS growth (last fiscal year) 88.30% 39.39% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALGS ANVS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.77 3.47 4.97
Net debt to EBITDA 0.87 0.66 1.01

Dividend

Metric ALGS ANVS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALGS ANVS Biotechnology median
Market cap 28.17m 28.55m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack